Home Newsletters Extracellular Matrix News Immunomodulation by Radiotherapy in Tumour Control and Normal Tissue Toxicity

Immunomodulation by Radiotherapy in Tumour Control and Normal Tissue Toxicity

0
The full scope of these immune changes remains unclear but is likely to involve multiple components, such as immune cells, the extracellular matrix, endothelial and epithelial cells and a myriad of chemokines and cytokines, including transforming growth factor-β.
[Nature Reviews Immunology]
6445218 {6445218:FB7GAIF7} apa 50 1 164214 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-940d58abc469b8f9efb432cffdb37ed8%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22FB7GAIF7%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cytlak%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECytlak%2C%20U.%20M.%2C%20Dyer%2C%20D.%20P.%2C%20Honeychurch%2C%20J.%2C%20Williams%2C%20K.%20J.%2C%20Travis%2C%20M.%20A.%2C%20%26amp%3B%20Illidge%2C%20T.%20M.%20%282021%29.%20Immunomodulation%20by%20radiotherapy%20in%20tumour%20control%20and%20normal%20tissue%20toxicity.%20%3Ci%3ENature%20Reviews%20Immunology%3C%5C%2Fi%3E%2C%201%26%23x2013%3B15.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41577-021-00568-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41577-021-00568-1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DFB7GAIF7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immunomodulation%20by%20radiotherapy%20in%20tumour%20control%20and%20normal%20tissue%20toxicity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Urszula%20M.%22%2C%22lastName%22%3A%22Cytlak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20P.%22%2C%22lastName%22%3A%22Dyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamie%22%2C%22lastName%22%3A%22Honeychurch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaye%20J.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Travis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20M.%22%2C%22lastName%22%3A%22Illidge%22%7D%5D%2C%22abstractNote%22%3A%22Radiotherapy%20%28RT%29%20is%20a%20highly%20effective%20anticancer%20treatment%20that%20is%20delivered%20to%20more%20than%20half%20of%20all%20patients%20with%20cancer.%20In%20addition%20to%20the%20well-documented%20direct%20cytotoxic%20effects%2C%20RT%20can%20have%20immunomodulatory%20effects%20on%20the%20tumour%20and%20surrounding%20tissues.%20These%20effects%20are%20thought%20to%20underlie%20the%20so-called%20abscopal%20responses%2C%20whereby%20RT%20generates%20systemic%20antitumour%20immunity%20outside%20the%20irradiated%20tumour.%20The%20full%20scope%20of%20these%20immune%20changes%20remains%20unclear%20but%20is%20likely%20to%20involve%20multiple%20components%2C%20such%20as%20immune%20cells%2C%20the%20extracellular%20matrix%2C%20endothelial%20and%20epithelial%20cells%20and%20a%20myriad%20of%20chemokines%20and%20cytokines%2C%20including%20transforming%20growth%20factor-%5Cu03b2%20%28TGF%5Cu03b2%29.%20In%20normal%20tissues%20exposed%20to%20RT%20during%20cancer%20therapy%2C%20acute%20immune%20changes%20may%20ultimately%20lead%20to%20chronic%20inflammation%20and%20RT-induced%20toxicity%20and%20organ%20dysfunction%2C%20which%20limits%20the%20quality%20of%20life%20of%20survivors%20of%20cancer.%20Here%20we%20discuss%20the%20emerging%20understanding%20of%20RT-induced%20immune%20effects%20with%20particular%20focus%20on%20the%20lungs%20and%20gut%20and%20the%20potential%20immune%20crosstalk%20that%20occurs%20between%20these%20tissues.%22%2C%22date%22%3A%222021-07-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41577-021-00568-1%22%2C%22ISSN%22%3A%221474-1741%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41577-021-00568-1%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-07-02T18%3A00%3A00Z%22%7D%7D%5D%7D
Cytlak, U. M., Dyer, D. P., Honeychurch, J., Williams, K. J., Travis, M. A., & Illidge, T. M. (2021). Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nature Reviews Immunology, 1–15. https://doi.org/10.1038/s41577-021-00568-1 Cite
Abstract
Exit mobile version